Bausch + Lomb Taking Phaco into the Future

May 1, 2017

Dear Eye Care Professional:

Fifty years ago, the introduction of phacoemulsification profoundly changed the way ophthalmologists performed cataract surgery. Today, we’re proud to help usher in the future of this innovative technology with our next-generation phaco platform, the Stellaris Elite™ vision enhancement system.

Since its first entry into the phaco market, Bausch + Lomb has worked to refine and improve upon its platforms to make the procedure more efficient, and meet the ever-evolving needs of customers like you. This commitment continues with Stellaris Elite, which features multiple innovations including Adaptive Fluidics™ and Attune® energy management systems, designed to work synergistically to deliver responsiveness and optimized control throughout the entire procedure. Additionally, while traditional capital equipment has a decade-long life cycle, Stellaris Elite will offer surgeons the opportunity to add upgrades and enhancements continuously, allowing them to customize and expand the capabilities over time.

For example, we’re proud to announce that the Vitesse™ vitreous cutter will be launched this summer. Vitesse is the first and only hypersonic, 100% open port vitrectomy system. This new technology represents a major advancement in vitreous removal innovation, and will be featured exclusively on the new Stellaris Elite vision enhancement system. You can read more about it here. We plan to launch Stellaris Elite for retina applications this summer, which will integrate both retina and cataract capabilities into a single machine. It will offer additional functionality and broad range of accessories and probes, including Vitesse.

In the meantime, we invite customers to experience the anterior features of the adaptable, cost-efficient, dual-function Stellaris Elite platform for themselves at the American Society of Cataract and Refractive Surgery (ASCRS) next week in Los Angeles, CA. During the interactive 30-minute wet lab sessions, surgeons will gain real time, hands-on experience with the new Stellaris Elite platform, as well as the VICTUS® femtosecond laser, and an extremely broad selection of intraocular lenses (IOLs) and delivery systems, which include the iSert® delivery system, a market-leading preloaded IOL, and the Crystalens® AO, TRULIGN® Toric, and the enVista® glistening-free acrylic IOLs. Attendees also will have the opportunity to hear firsthand from the engineers and researchers who are responsible for the development of Bausch + Lomb’s surgical suite of technologies and learn pearls and techniques. For more information and to schedule an appointment in the wet lab visit:

Other innovations showcased at our ASCRS booth (#2023) include the new Osher “No Fly” instrument set, developed in partnership with Robert Osher, M.D., professor of Ophthalmology at the College of Medicine of the University of Cincinnati and medical director emeritus of the Cincinnati Eye Institute. These instruments were designed to work under overhead technology to help minimize the risk of instruments hitting attachments, such as aberometers, that fall below the scope, potentially rendering them no longer sterile. The new instrument set will provide the same functionality as commonly used instruments in cataract procedures, but feature shorter handles to help improve surgeon’s maneuverability.

In addition to the activity at our booth, we invite you to take advantage of these Bausch + Lomb-supported educational events, which feature a diverse group of highly regarded speakers:

Cataract-Focused Symposia on Sunday, May 7
Led by program chair, John Hovanesian, M.D., “Integrating Premium Technology for Excellent Outcomes,” will be open to meeting attendees on Sunday, May 7 at the Los Angeles Convention Center (West Hall B). The educational program will include the following faculty; Cynthia Matossian, M.D., Inder Paul Singh, M.D., and Mitch. C. Shultz, M.D. Registration and breakfast begins at 6 a.m., with the program commencing at 6:30 a.m. Attendees can register online at:

Industry Spotlight Theater
The Industry Spotlight Theater offered by ASCRS ASOA Symposium & Congress is a new series of exhibit hall-based educational programming designed to provide attendees the opportunity to learn about different ophthalmic products and categories. A distinguished group of speakers will moderate the sessions, several of which will include discussion of technologies from the Bausch + Lomb surgical portfolio. These events include:

  • Sunday, May 7 from 11 a.m. to Noon p.m., the FLACS/Capsulotomies session, featuring the VICTUS femtosecond laser;
  • Monday, May 8, from 9 to 10 a.m., the Cataract Surgery Small Instruments/Devices session, featuring the Osher “no fly” instrument set;
  • Sunday, May 7 from 9 to 10 a.m., the Phaco Machines session, featuring the company’s new next-generation phacoemulsification system, the Stellaris Elite.

Finally, 20 podium presentations and e-posters will feature Bausch + Lomb’s Surgical products at ASCRS this year. This is a testament to the great performance and exceptional outcomes surgeons are achieving with our technology.

It’s been an exciting 50 years in ophthalmology, and we’re working to ensure that the excitement continues for the next 50 and beyond. As your partner on this journey, I want to thank you for your support and invite you to reach out to me directly at with any comments, questions or suggestions. It’s your candid feedback and insights that help us deliver the customer service and technology that you deserve.

I look forward to seeing you in Los Angeles.

Best regards,


Chuck Hess   
Vice President & General Manager
U.S. Surgical, Bausch + Lomb      

®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates. iSert is a trademark of Hoya Surgical Optics GmbH.
Any other product/brand names are trademarks of the respective owners. © 2017 Bausch & Lomb Incorporated.